Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Webber Chan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Medicine|October 4, 2021
Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or UveitisAlfred Yu Ting Chia, Gladys Wei Xin Ang, Anita Sook Yee Chan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2017
Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disabilityWebber Chan, Hang Hock Shim, Miao Shan Lim, et al.
Journal of Crohn'S & Colitis|September 15, 2018
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic AreasWebber Chan, Hang Hock Shim, Siew Chien Ng, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2018
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel diseaseWebber Chan, Nicole Lynch, Peter Bampton, et al.
The Medical Journal of Australia|January 27, 2021
High prevalence of Crohn disease and ulcerative colitis among older people in SydneyAviv Pudipeddi, Jeffrey Liu, Viraj Kariyawasam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 22, 2020
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE studyJesus K Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, et al.
Pharmacogenomics|December 7, 2017
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patientsNatalia Sutiman, Sylvia Chen, Khoon Lin Ling, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
The Pharmacogenomics Journal|December 10, 2019
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patientsSylvia Chen, Wei Zhi Tan, Natalia Sutiman, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|October 4, 2021
Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or UveitisAlfred Yu Ting Chia, Gladys Wei Xin Ang, Anita Sook Yee Chan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2017
Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disabilityWebber Chan, Hang Hock Shim, Miao Shan Lim, et al.
Journal of Crohn'S & Colitis|September 15, 2018
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic AreasWebber Chan, Hang Hock Shim, Siew Chien Ng, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2018
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel diseaseWebber Chan, Nicole Lynch, Peter Bampton, et al.
The Medical Journal of Australia|January 27, 2021
High prevalence of Crohn disease and ulcerative colitis among older people in SydneyAviv Pudipeddi, Jeffrey Liu, Viraj Kariyawasam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 22, 2020
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE studyJesus K Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, et al.
Pharmacogenomics|December 7, 2017
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patientsNatalia Sutiman, Sylvia Chen, Khoon Lin Ling, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
The Pharmacogenomics Journal|December 10, 2019
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patientsSylvia Chen, Wei Zhi Tan, Natalia Sutiman, et al.
Pageof 3